Astera Labs (NASDAQ:ALAB) Given New $230.00 Price Target at Susquehanna

Key Points

• Susquehanna raised its price target on Astera Labs from $155 to $230 while maintaining a "neutral" rating, implying roughly an 11% upside from the current share price.
• Astera Labs beat Q1 expectations with $0.61 EPS vs. $0.54 consensus and revenue of $308.4M (+93% YoY), and issued stronger Q2 guidance (EPS $0.68–$0.70; revenue $355–$365M) supported by new shipments of its Scorpio X‑Series switch.
• Despite strong results and analyst interest, the stock carries a high valuation (P/E ~169.6), insiders have sold over 1.06M shares in the past three months, and the MarketBeat consensus is a "Moderate Buy" with an average target of $216.15.

Astera Labs (NASDAQ:ALAB - Get Free Report) had its price objective hoisted by investment analysts at Susquehanna from $155.00 to $230.00 in a report released on Wednesday,Benzinga reports. The brokerage presently has a "neutral" rating on the stock. Susquehanna's price target indicates a potential upside of 11.01% from the company's current price.

Several other equities research analysts also recently issued reports on the stock. UBS Group initiated coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a "neutral" rating and a $180.00 price objective on the stock. Morgan Stanley restated an "overweight" rating and issued a $240.00 price objective on shares of Astera Labs in a research note on Wednesday. Citigroup restated a "buy" rating on shares of Astera Labs in a research note on Wednesday. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a "neutral" rating and a $153.00 price objective on the stock. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $250.00 price objective on shares of Astera Labs in a research note on Tuesday, April 21st. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Astera Labs currently has a consensus rating of "Moderate Buy" and a consensus price target of $216.15.

Astera Labs Stock Down 3.9%

Shares of NASDAQ:ALAB traded down $8.50 during trading on Wednesday, reaching $207.20. The stock had a trading volume of 3,184,246 shares, compared to its average volume of 5,314,226. Astera Labs has a 52 week low of $63.40 and a 52 week high of $262.90. The firm has a market capitalization of $35.49 billion, a price-to-earnings ratio of 169.55, a P/E/G ratio of 3.96 and a beta of 3.35. The stock has a fifty day simple moving average of $140.72 and a two-hundred day simple moving average of $153.38.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. Astera Labs's quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter last year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, analysts forecast that Astera Labs will post 1.48 EPS for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the sale, the director owned 319,863 shares in the company, valued at $34,420,457.43. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of Astera Labs stock in a transaction on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the sale, the director owned 67,144 shares in the company, valued at $11,758,257.28. This represents a 5.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,064,888 shares of company stock worth $150,764,723 over the last three months. 12.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently bought and sold shares of the business. Assetmark Inc. boosted its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company's stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Reflection Asset Management acquired a new stake in shares of Astera Labs in the 4th quarter valued at $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company's stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Hilltop National Bank boosted its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company's stock valued at $33,000 after purchasing an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs in the 4th quarter valued at $33,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 results: Astera Labs posted a multi‑point beat — $0.61 EPS vs. $0.54 consensus and revenue of $308.4M (+93% YoY). Management highlighted record revenue and expanding margins, which validates current growth expectations. Astera Labs Bulls Stay In Control Following Earnings Double Beat, Strong Q2 Guidance
• Positive Sentiment: Raised Q2 guidance: Company issued Q2 EPS guide of $0.68–$0.70 and revenue guide ($355M–$365M) well above street estimates, creating strong forward visibility for next quarter. Astera Labs Reports First Quarter 2026 Financial Results
• Positive Sentiment: New product momentum: Astera began shipping the Scorpio X‑Series 320‑lane smart fabric switch to hyperscalers — strengthens position in AI scale‑up networking and supports future revenue growth. Astera Labs Extends Leadership in Open, AI Scale-Up Networking with New 320 Lane Scorpio X-Series Smart Fabric Switch
• Positive Sentiment: Analyst upgrades/price‑target lifts: Stifel Nicolaus and Needham raised targets to $260 and maintain buy ratings, supplying fresh buy‑side momentum and signaling increased sell‑side conviction. Benzinga
• Positive Sentiment: Market commentary and investor interest: Several outlets and commentators (Seeking Alpha, TipRanks, MarketWatch, Jim Cramer mention) highlighted robust AI demand and the company’s strategic role in accelerator connectivity, helping sentiment. Astera Labs: Superb Q1, But Faster Times Ahead
• Neutral Sentiment: Earnings call / transcripts available: Investors can review the Q1 earnings transcript for detail on product roadmap, gross‑margin dynamics and hyperscaler engagements to assess sustainability of the beat. Astera Labs, Inc. (ALAB) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Valuation questions: Coverage notes and a valuation piece flag that recent momentum has pushed multiples higher (ALAB sports a high P/E and elevated beta), so upside is contingent on continued outsized execution — raising short‑term risk of multiple contraction if growth slows. Assessing Whether Astera Labs (ALAB) Is Overvalued After Its Strong Recent Share Price Momentum

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.